awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q52677958-23F2AE33-5D43-49F6-BB14-226E74DCBE63
Q52677958-23F2AE33-5D43-49F6-BB14-226E74DCBE63
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52677958-23F2AE33-5D43-49F6-BB14-226E74DCBE63
Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.
P2860
Q52677958-23F2AE33-5D43-49F6-BB14-226E74DCBE63
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52677958-23F2AE33-5D43-49F6-BB14-226E74DCBE63
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2b7c8d13e37a6b31a22273bbb2a78f94c00e287
P2860
Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.